Anxiety & Depression in Thyroid Cancer Patients

February 20, 2024 updated by: Salma Mamdouh Mohammed Mahmoud, Assiut University

Anxiety, Depression and Quality of Life in Thyroid Cancer Patients

  1. To identify the prevalence of both anxiety and depression in thyroid cancer patients
  2. To assess quality of life in thyroid cancer patients

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

In recent years, increasing attention has been paid to mental health among cancer patients.

Thyroid cancer is one of the most frequent endocrine neoplasia. It consists of 4 subtypes of papillary thyroid cancer, follicular thyroid cancer, medullary thyroid cancer, and anaplastic thyroid cancer.

Which is usually asymptomatic in the early stages, but symptoms such as neck pain, hoarseness, and dysphagia may occur as the disease progresses. TC is diagnosed by physical examination, analysis of thyroid hormone levels, imaging, and biopsy.

Anxiety and depression are the most common psychological problems in the treatment of cancer patients and are related to the majority of medical diseases and physical symptoms.

Studies have suggested that anxiety and depression are common in patients with thyroid cancer.

Therefore, quality of life which includes psychological, social, and spiritual well-being, has become an important consideration .

These findings highlight the importance of identifying thyroid cancer patients needs to allow better and more adequate care and support.

Study Type

Observational

Enrollment (Estimated)

159

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

thyroid cancer patients

Description

Inclusion Criteria:

  1. Age at or more than 18 years old
  2. None of the patients had history of other psychiatric illness
  3. Both sex
  4. Accept to participate in the study

Exclusion Criteria:

  1. Age less than 18 years old
  2. Previous history of other psychiatric illness
  3. substance abuser or dependence
  4. Refuse to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the prevalence of anxiety in thyroid cancer patients
Time Frame: baseline
To identify the prevalence of anxiety in thyroid cancer patients by using Hamilton Anxiety Rating Scale
baseline
the prevalence of depression in thyroid cancer patients
Time Frame: baseline
To identify the prevalence of depression in thyroid cancer patients by using Hamilton Depression Rating Scale
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
assess quality of life in thyroid cancer patients
Time Frame: baseline
Detect quality of life in patients with thyroid cancer by using Short form 36 Quality of life questionnaire
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2024

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

March 1, 2026

Study Registration Dates

First Submitted

February 6, 2024

First Submitted That Met QC Criteria

February 20, 2024

First Posted (Estimated)

February 21, 2024

Study Record Updates

Last Update Posted (Estimated)

February 21, 2024

Last Update Submitted That Met QC Criteria

February 20, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Thyroid cancer

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thyroid Cancer

Clinical Trials on Hamilton depression Rating Scale

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe